---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-24-000023"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:39:51.274625+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Summit Therapeutics to present at Oppenheimer Healthcare Conference on Feb 14

## Summary
- Presentation at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024 at 2:40PM ET.
- Dr. Maky Zanganeh (CEO/President) and Robert W. Duggan (Chairman/CEO) will present on ivonescimab development.
- Webcast available live and archived on Summit's website at www.smmttx.com.

## SEC filing metadata
- accession: 0001599298-24-000023
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000023/0001599298-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000023/smmt-20240207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-24-000023
- JSON: https://secwatch.observer/filing/0001599298-24-000023.json
- Plain text: https://secwatch.observer/filing/0001599298-24-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.